| 1022 Tumor-infiltrating CXCR6-expressing tissue-resident memory HPV-specific CD8+ T cells are terminally exhausted in HPV-associated head and neck squamous cell carcinoma Y Cheng, K Atkinson, T Saal, J Campbell, S Pai Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| 354 A phase 1 trial of CUE-101 a novel HPV16 E7-pHLA-IL2-Fc fusion protein in patients with recurrent/metastatic HPV16+ head and neck cancer S Pai, D Adkins, L Wirth, C Chung, M Gibson, A Sukari, F Worden, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | 1 | 2020 |
| 438 A phase 1 trial of CUE-101, a novel HPV16 E7-pHLA-IL2-Fc fusion protein, alone and in combination with pembrolizumab in patients with recurrent/metastatic HPV16+ head and … C Chung, AD Colevas, M Gibson, D Adkins, A Sukari, L Wirth, B Burtness, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021 | 2 | 2021 |
| 674 A phase 1 dose-escalation and expansion study of CUE-101, given as monotherapy in 3L and in combination with pembrolizumab in 1L recurrent/metastatic HPV16+ head and neck … CH Chung, D Adkins, AD Colevas, C Rodriguez, JC Park, MK Gibson, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 681 A phase 1 study of CUE-101, a novel HPV16 E7-pHLA-IL2-Fc fusion protein, as monotherapy and in combination with pembrolizumab in patients with recurrent/metastatic HPV16+ … C Chung, D Colevas, D Adkins, JC Park, C Rodriguez, M Gibson, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| 82nd Annual Meeting of the American Thyroid AssociationMEETING ABSTRACTS & PROGRAM N Schoenmakers, B Bak, Y Sun, PVAN Trotsenburg, W Oostdijk, P Voshol, ... Thyroid (New York, NY) 22 (S1), A-1-A-124, 2012 | | 2012 |
| A DNA vaccine co-expressing antigen and an anti-apoptotic molecule further enhances the antigen-specific CD8+ T-cell immune response TW Kim, CF Hung, M Zheng, DAK Boyd, L He, SI Pai, TC Wu Journal of biomedical science 11, 493-499, 2004 | 57 | 2004 |
| A MODEL OF THE MESSENGER-RNA SPLICING DEFECT IN ADULT LYSOSOMAL STORAGE DISEASE (GLYCOGENOSIS TYPE-II) N RABEN, J ZARETSKY, RC NICHOLS, SI PAI, PH PLOTZ AMERICAN JOURNAL OF HUMAN GENETICS 57 (4), 1444-1444, 1995 | | 1995 |
| A new model to enhance enrollment of diverse participants to therapeutic clinical trials. PY Ryan, JM Brain, SI Pai, HK Lyerly, JL Harris Journal of Clinical Oncology 42 (16_suppl), TPS1640-TPS1640, 2024 | | 2024 |
| A phase 1 dose-escalation and expansion study of CUE-101, a novel HPV16 E7-pHLA-IL2-Fc fusion protein, given alone and in combination with pembrolizumab in patients with … CH Chung, AD Colevas, D Adkins, MK Gibson, CP Rodriguez, A Sukari, ... Journal of Clinical Oncology 40 (16_suppl), 6045-6045, 2022 | 12 | 2022 |
| A phase 1 dose-escalation and expansion study of CUE-101, a novel HPV16 E7-pHLA-IL2-Fc fusion protein, given as monotherapy and in combination with pembrolizumab in patients … CH Chung, ADD Colevas, D Adkins, CP Rodriguez, JC Park, MK Gibson, ... Journal of Clinical Oncology 41 (16_suppl), 6013-6013, 2023 | 6 | 2023 |
| A phase 1 dose-escalation and expansion study of CUE-101, given as monotherapy and in combination with pembrolizumab, in patients with recurrent/metastatic HPV16+ head and neck … AD Colevas, CH Chung, D Adkins, CP Rodriguez, JC Park, MK Gibson, ... Journal of Clinical Oncology 42 (16_suppl), 6004-6004, 2024 | | 2024 |
| A Phase 1 Dose-escalation and Expansion Study of CUE-101, Given As Monotherapy in 3rd Line and in Combination with Pembrolizumab in 1st Line Recurrent/Metastatic (R/M) HPV16+ … AD Colevas, CH Chung, D Adkins, CP Rodriguez, JC Park, MK Gibson, ... International Journal of Radiation Oncology, Biology, Physics 118 (5), e87, 2024 | | 2024 |
| A PHASE 1 STUDY OF CUE-101, A NOVEL HPV16 E7PHLA-IL2-FC FUSION PROTEIN, AS MONOTHERAPY AND IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH RECURRENT/METASTATIC HPV16+ HEAD … C Chung, D Colevas, D Adkins, JC Park, C Rodriguez, M Gibson, ... JOURNAL FOR IMMUNOTHERAPY OF CANCER 10, A711-A711, 2022 | 2 | 2022 |
| A phase Ib multicohort study of MK-3475 in patients with advanced solid tumors. R Nanda, ER Plimack, EC Dees, S Gupta, R Berger, A Elfiky, L Pusztai, ... Journal of Clinical Oncology 32 (15_suppl), TPS3119-TPS3119, 2014 | 11 | 2014 |
| A phase Ib study of MK-3475 in patients with human papillomavirus (HPV)-associated and non-HPV–associated head and neck (H/N) cancer. TY Seiwert, B Burtness, J Weiss, I Gluck, JP Eder, SI Pai, M Dolled-Filhart, ... Journal of Clinical Oncology 32 (15_suppl), 6011-6011, 2014 | 166 | 2014 |
| A phase II study of pembrolizumab for HPV-associated papilloma patients with laryngeal, tracheal, and/or pulmonary involvement. SI Pai, A Muniappan, JC Park, AD Friedman, NP Campbell, SB Krantz, ... Journal of Clinical Oncology 40 (16_suppl), 2590-2590, 2022 | 4 | 2022 |
| A phase II study of pembrolizumab for HPV-associated papilloma patients with laryngeal, tracheal, and/or pulmonary involvement. SI Pai, AD Friedman, R Franco, A Muniappan, JC Park, NP Campbell, ... Journal of Clinical Oncology 37 (15_suppl), 2502-2502, 2019 | 11 | 2019 |
| A rabbit model to investigate temporomandibular joint osteochondral regeneration JLGC Monteiro, T Takusagawa, BCE Vasconcelos, SI Pai, JP McCain, ... Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 134 (1), 20-27, 2022 | 4 | 2022 |
| A randomized phase 2 study of pembrolizumab with or without radiation in patients with recurrent or metastatic adenoid cystic carcinoma U Mahmood, A Bang, YH Chen, RH Mak, JH Lorch, GJ Hanna, M Nishino, ... International Journal of Radiation Oncology* Biology* Physics 109 (1), 134-144, 2021 | 71 | 2021 |
